The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124479502 12447950 2 F 20160727 20160608 20160803 EXP IT-PFIZER INC-2016292023 PFIZER ROTA, E.. IATROGENIC COAGULOPATHY AND THE DEVELOPMENT OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME AFTER L-ASPARAGINASE CHEMOTHERAPY.. JOURNAL OF CLINICAL IMAGING SCIENCE. 2016;6(1):ARTICLE NUMBER 7 65.00 YR F Y 0.00000 20160803 MD IT IT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124479502 12447950 1 PS METHOTREXATE. METHOTREXATE 1 Intrathecal UNK Y 11719
124479502 12447950 2 SS DAUNORUBICIN HCL DAUNORUBICIN HYDROCHLORIDE 1 Intravenous drip UNK Y 0
124479502 12447950 3 SS DEXAMETHASONE SODIUM PHOSPHATE. DEXAMETHASONE SODIUM PHOSPHATE 1 30 MG/M2, UNK (30 MG/M2/DIE) Y 0 30 MG/M**2
124479502 12447950 4 C VINCRISTINE VINCRISTINE 1 ADMINISTERED ON DAYS 8, 15, AND 22 AND STOPPED ON DAY 29 0
124479502 12447950 5 C L-ASPARAGINASE ASPARAGINASE 1 Intravenous drip UNK, ON DAYS 18, 21, 24, AND 27 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124479502 12447950 1 Acute lymphocytic leukaemia
124479502 12447950 2 Acute lymphocytic leukaemia
124479502 12447950 3 Acute lymphocytic leukaemia
124479502 12447950 4 Acute lymphocytic leukaemia
124479502 12447950 5 Acute lymphocytic leukaemia

Outcome of event

Event ID CASEID OUTC COD
124479502 12447950 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124479502 12447950 Neuropathy peripheral

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found